Brief: Lexicon Pharmaceuticals Q1 Operating Income USD -25.679 Million
13/05/2025 21:12
May 13 (Reuters) - Lexicon Pharmaceuticals Inc LXRX.O: LEXICON PHARMACEUTICALS Q1 OPERATING INCOME USD -25.679 MILLION LEXICON PHARMACEUTICALS Q1 OPERATING EXPENSES USD 26.941 MILLION LEXICON PHARMACEUTICALS Q1 NET INCOME USD -25.295 MILLION LEXICON PHARMACEUTICALS Q1 BASIC EPS USD -0.07 LEXICON PHARMACEUTICALS INC: ON TRACK FOR NEXT STEPS IN PILAVAPADIN'S DEVELOPMENT, INCLUDING OUR END OF PHASE 2 MEETING WITH FDA Source text: ID:nGNXbnn131 Further company coverage: LXRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lexicon Pharmaceuticals
See all newsLexicon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Lexicon Pharmaceuticals posts Q2 net loss
Brief: Lexicon Pharmaceuticals Q2 EPS USD -0.07
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview